Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells
Authors:
- Jaume PonsJPJaume Pons
- Alvar AgustíAAAlvar Agustí
- Joan B. SorianoJSJoan B. Soriano
- Borja G. CosioBorja G. Cosio
- Juan A. TorrecillaJTJuan A. Torrecilla
- Belén NúñezBNBelén Núñez
- Rocío CórdovaRCRocío Córdova
- Amanda IglesiasAIAmanda Iglesias
- Andreas JahnAJAndreas Jahn
- Catalina CrespiCCCatalina Crespi
- Jaume SauledaJSJaume Sauleda
- 1 December 2013
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 107 (12) , 1895-1903
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Immunologic Aspects of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2009
- Regulatory T Cells and Immune ToleranceCell, 2008
- Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smokingEuropean Respiratory Journal, 2007
- CD4-Regulatory Cells in COPD PatientsChest, 2007
- Antielastin autoimmunity in tobacco smoking–induced emphysemaNature Medicine, 2007
- Immunosurveillance and Immunoregulation by γδ T CellsJournal of Investigative Dermatology, 2006
- Blunted γδ T-lymphocyte response in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2005
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- End-Stage Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001